• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Delayed-onset Nodules (DONs) and Considering their Treatment following use of Hyaluronic Acid (HA) Fillers.迟发性结节(DONs)以及使用透明质酸(HA)填充剂后的治疗考量
J Clin Aesthet Dermatol. 2021 Jul;14(7):E59-E67. Epub 2021 Jul 1.
2
Radial Sound (Shockwave) Therapy Resolves Delayed-onset Nodules Following Injection of Hyaluronic Acid Dermal Filler: A Case Study.桡侧声波(冲击波)疗法治疗透明质酸真皮填充剂注射后迟发性结节:病例报告
J Clin Aesthet Dermatol. 2021 Dec;14(12 Suppl 1):S15-S17.
3
Management of noninflammatory nodule in chin after a large volume bolus injection of hyaluronic acid filler.大剂量推注透明质酸填充剂后下巴非炎性结节的处理
Dermatol Ther. 2020 May;33(3):e13424. doi: 10.1111/dth.13424. Epub 2020 May 7.
4
Etiology of Delayed Inflammatory Reaction Induced by Hyaluronic Acid Filler.透明质酸填充剂引起的迟发性炎症反应的病因学
Arch Plast Surg. 2024 Feb 7;51(1):20-26. doi: 10.1055/a-2184-6554. eCollection 2024 Jan.
5
Guideline for the Management of Hyaluronic Acid Filler-induced Vascular Occlusion.透明质酸填充剂所致血管阻塞的管理指南
J Clin Aesthet Dermatol. 2021 May;14(5):E61-E69. Epub 2021 May 1.
6
Delayed-Onset Nodules to Differentially Crosslinked Hyaluronic Acids: Comparative Incidence and Risk Assessment.延迟出现的结节对差异化交联透明质酸的影响:比较发生率和风险评估。
Dermatol Surg. 2019 Aug;45(8):1085-1094. doi: 10.1097/DSS.0000000000001814.
7
Global Approaches to the Prevention and Management of Delayed-onset Adverse Reactions with Hyaluronic Acid-based Fillers.基于透明质酸填充剂的迟发性不良反应预防与管理的全球方法
Plast Reconstr Surg Glob Open. 2020 Apr 29;8(4):e2730. doi: 10.1097/GOX.0000000000002730. eCollection 2020 Apr.
8
Rehabilitation of the Dysmorphic Lower Eyelid From Hyaluronic Acid Filler: What to Do After a Good Periocular Treatment Goes Bad.透明质酸填充剂导致的畸形下眼睑修复:良好的眼周治疗效果不佳后该如何处理。
Aesthet Surg J. 2020 Jan 29;40(2):197-205. doi: 10.1093/asj/sjz078.
9
Guideline for the Safe Use of Hyaluronidase in Aesthetic Medicine, Including Modified High-dose Protocol.美容医学中透明质酸酶安全使用指南,包括改良高剂量方案。
J Clin Aesthet Dermatol. 2021 Aug;14(8):E69-E75. Epub 2021 Aug 1.
10
Quantitative Correlation Between Hyaluronic Acid Filler and Hyaluronidase.透明质酸填充剂与透明质酸酶之间的定量相关性
J Craniofac Surg. 2017 May;28(3):838-841. doi: 10.1097/SCS.0000000000003411.

引用本文的文献

1
Properties and potentialities of hyaluronic acid and eXcellent Tridimensional Reticulation as a filling agent: a review.透明质酸和卓越三维网状结构作为填充剂的特性与潜力:综述
Drugs Context. 2025 Aug 13;14. doi: 10.7573/dic.2025-1-1. eCollection 2025.
2
Aesthetic Treatment Considerations in Patients with Cutaneous Autoimmune Disease.皮肤自身免疫性疾病患者的美学治疗考量
J Clin Aesthet Dermatol. 2025 Jul 1;18(7):26-29.
3
Successful Treatment of Delayed Onset Nodules After Dermal Fillers Injection with Abrocitinib: A Case Report.使用阿布昔替尼成功治疗填充剂注射后迟发性结节:一例报告
Clin Cosmet Investig Dermatol. 2025 Apr 16;18:955-959. doi: 10.2147/CCID.S524045. eCollection 2025.
4
Lip Sonoanatomy and Relevance to Aesthetic Filler Injections: A Pictorial Review.唇部超声解剖及其与美容填充注射的相关性:图文综述
J Cosmet Dermatol. 2025 Apr;24(4):e70164. doi: 10.1111/jocd.70164.
5
Clinical Management of Poly-D,L-Lactic Acid Nodules: A Guideline With Diagnostic and Treatment Flowchart.聚-D,L-乳酸结节的临床管理:一份带有诊断和治疗流程图的指南
J Cosmet Dermatol. 2025 Apr;24(4):e70158. doi: 10.1111/jocd.70158.
6
Energy-Based Device Management of Nodular Reaction Following Poly-D, L-Lactic Acid Injection for Tear Trough Rejuvenation.聚-D,L-乳酸注射用于泪沟年轻化后结节反应的基于能量的设备管理。
J Cosmet Dermatol. 2025 Jan;24(1):e16575. doi: 10.1111/jocd.16575. Epub 2024 Sep 16.
7
Late-Onset Reactions after Hyaluronic Acid Dermal Fillers: A Consensus Recommendation on Etiology, Prevention and Management.透明质酸真皮填充剂的迟发性反应:关于病因、预防和管理的共识建议
Dermatol Ther (Heidelb). 2024 Jul;14(7):1767-1785. doi: 10.1007/s13555-024-01202-3. Epub 2024 Jun 22.
8
The emerging topic of injected cosmetic fillers in the perinasal region of dromedary camels: ultrasonographic and radiographic verification.注射式美容填充物在单峰驼鼻部区域的新兴研究课题:超声和放射影像学验证。
Open Vet J. 2024 Mar;14(3):840-845. doi: 10.5455/OVJ.2024.v14.i3.11. Epub 2024 Mar 31.
9
One-Year Safety Evaluation of New Hyaluronic Acid Fillers (YYS Series): A Prospective, Multicenter, Observational Study.新型透明质酸填充剂(YYS 系列)的一年安全性评估:一项前瞻性、多中心、观察性研究。
Dermatol Surg. 2024 Aug 1;50(8):731-738. doi: 10.1097/DSS.0000000000004190. Epub 2024 May 2.
10
Delayed hypersensitivity reaction to cosmetic filler following two COVID-19 vaccinations and infection.在两次接种新冠病毒疫苗及感染后对美容填充剂出现的迟发型超敏反应。
Allergy Asthma Clin Immunol. 2023 Apr 20;19(1):31. doi: 10.1186/s13223-023-00788-1.

本文引用的文献

1
Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II-induced cutaneous inflammation.口服血管紧张素转换酶抑制剂治疗新冠病毒疫苗接种后对真皮透明质酸填充剂的迟发性炎症反应——一种抑制血管紧张素II诱导的皮肤炎症的模型
JAAD Case Rep. 2021 Apr;10:63-68. doi: 10.1016/j.jdcr.2021.02.018. Epub 2021 Mar 2.
2
"COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment".“COVID-19/SARS-CoV-2 病毒刺突蛋白相关的透明质酸真皮填充剂延迟性炎症反应:诊断和治疗中的具有挑战性的临床难题”。
Arch Dermatol Res. 2022 Jan;314(1):1-15. doi: 10.1007/s00403-021-02190-6. Epub 2021 Feb 9.
3
Increased risk of late-onset, immune-mediated, adverse reactions related to dermal fillers in patients bearing HLA-B*08 and DRB1*03 haplotypes.携带 HLA-B*08 和 DRB1*03 单倍型的患者中,真皮填充剂相关迟发性、免疫介导的不良反应风险增加。
Dermatol Ther. 2021 Jan;34(1):e14644. doi: 10.1111/dth.14644. Epub 2020 Dec 19.
4
Granulomas and nongranulomatous nodules after filler injection: Different complications require different treatments.填充剂注射后出现的肉芽肿和非肉芽肿性结节:不同的并发症需要不同的治疗方法。
J Plast Reconstr Aesthet Surg. 2020 Nov;73(11):2010-2015. doi: 10.1016/j.bjps.2020.08.012. Epub 2020 Aug 13.
5
Basic rheology of dermal filler.真皮填充剂的基础流变学
Arch Plast Surg. 2020 Jul;47(4):301-304. doi: 10.5999/aps.2020.00731. Epub 2020 Jul 15.
6
Delayed Inflammatory Reactions to Hyaluronic Acid Fillers: A Literature Review and Proposed Treatment Algorithm.透明质酸填充剂的迟发性炎症反应:文献综述及建议的治疗方案
Clin Cosmet Investig Dermatol. 2020 May 18;13:371-378. doi: 10.2147/CCID.S247171. eCollection 2020.
7
Topical stabilized hypochlorous acid: The future gold standard for wound care and scar management in dermatologic and plastic surgery procedures.局部稳定次氯酸:皮肤科和整形手术中伤口护理和疤痕管理的未来金标准。
J Cosmet Dermatol. 2020 Feb;19(2):270-277. doi: 10.1111/jocd.13280. Epub 2020 Jan 6.
8
Practical Approach and Safety of Hyaluronic Acid Fillers.透明质酸填充剂的实用方法与安全性
Plast Reconstr Surg Glob Open. 2019 Jun 14;7(6):e2172. doi: 10.1097/GOX.0000000000002172. eCollection 2019 Jun.
9
Cetuximab associated dermal filler reaction.西妥昔单抗相关的真皮填充剂反应。
BMJ Case Rep. 2019 Aug 26;12(8):e228882. doi: 10.1136/bcr-2018-228882.
10
A Systematic Review of the Literature of Delayed Inflammatory Reactions After Hyaluronic Acid Filler Injection to Estimate the Incidence of Delayed Type Hypersensitivity Reaction.透明质酸填充剂注射后迟发性炎症反应的文献系统评价,以估计迟发型超敏反应的发生率。
Aesthet Surg J. 2020 Apr 14;40(5):NP286-NP300. doi: 10.1093/asj/sjz222.

迟发性结节(DONs)以及使用透明质酸(HA)填充剂后的治疗考量

Delayed-onset Nodules (DONs) and Considering their Treatment following use of Hyaluronic Acid (HA) Fillers.

作者信息

Convery Cormac, Davies Emma, Murray Gillian, Walker Lee

机构信息

Dr. Convery is with The Ever Clinic Glasgow in Glasgow, Scotland.

Ms. Davies is the Clinical Director of Save Face UK.

出版信息

J Clin Aesthet Dermatol. 2021 Jul;14(7):E59-E67. Epub 2021 Jul 1.

PMID:34840652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8570356/
Abstract

Delayed-onset nodules (DONs) represent a poorly understood and generally neglected group of complications. It is not a diagnosis. The underlying pathologies and their incidences are largely unknown due to the lack of specificity in clinical signs and the challenges in accessing diagnostic tests, cost implications, or reluctance from patients to undergo them. A lack of presumptive clinical diagnosis, coupled with management ranging from "scatter-gun" polypharmacy to clinical inertia, is believed to result in chronicity and increased morbidity. This paper provides guidance on the identification and understanding of the underlying pathologies and encourages the increased utilization of a medical model of care. The more routine adoption of histopathology, inflammatory markers, and ultrasound will permit a more targeted management and a greater understanding of the incidences and evolution of the pathologies.

摘要

迟发性结节(DONs)是一类理解不足且普遍被忽视的并发症。它并非一种诊断。由于临床体征缺乏特异性,以及获取诊断检测存在挑战、成本问题或患者不愿接受检测,其潜在病理情况及其发生率在很大程度上尚不明确。据信,缺乏初步临床诊断,再加上从“散弹枪式”联合用药到临床惰性的管理方式,会导致病情慢性化和发病率增加。本文就潜在病理情况的识别与理解提供指导,并鼓励更多地采用医疗照护模式。更常规地采用组织病理学、炎症标志物和超声检查将有助于进行更有针对性的管理,并更深入地了解这些病理情况的发生率和演变过程。